Skip to main content
. Author manuscript; available in PMC: 2024 Sep 17.
Published in final edited form as: J Nucl Cardiol. 2018 Nov 7;27(2):562–572. doi: 10.1007/s12350-018-01505-x

Figure 2.

Figure 2.

Scatterplots of the motion scores (in mm) of segment #12 obtained with reduced dose vs with full dose for FBP reconstruction. From left to right: 50%, 25%, 12.5% dose, and personalized dose. Red dots: abnormal motion cases (67 total), blue dots: normal motion cases (96 total).